Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SAMDI Tech, WuXi Reach Milestone in Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

SAMDI Tech, WuXi Reach Milestone in Partnership

Provides more than one million compounds in its small molecule screening collection, in part through a partnership with WuXi AppTec’s LabNetwork

By: Betsy Louda

, Contract Pharma

SAMDI Tech Inc. has provided more than one million compounds in its small molecule screening collection, in part through a partnership with WuXi AppTec’s LabNetwork. LabNetwork, a WuXiAppTec company, will facilitate the delivery of the compounds to SAMDI Tech from WuXi’s global network of providers.
 
SAMDI Tech simplifies and streamlines drug candidate screening using its proprietary high-throughput SAMDI (Self-Assembled Monolayer Desorption Ionization) assay. The better, faster label-free technology allows SAMDI Tech’s clients to select from any or even all of the compounds available to screen against their target. The partnership will provide access to WuXi’s commercial collection of more than 300,000 compounds, further diversifying the number of compounds and compound class choices available through SAMDI Tech.
 
“We are committed to helping our clients advance their drug discovery pipelines. By increasing the chance of finding a hit with the right characteristics for development, we ultimately help clients bring new and better therapies to market for patients around the world,” said Emilio Córdova, Ph.D., MBA, chief executive officer at SAMDI Tech.
 

“WuXi-LabNetwork is pleased to make the WuXi compounds available to SAMDI Tech’s customers through this new arrangement,” said Xuanjia Peng, head of WuXi-LabNetwork. “Now customers who choose their label-free technology can also access the novel compounds from WuXi.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics